# Transcranial Photobiomodulation for Bipolar Depression

> **NCT07510646** · NA · NOT_YET_RECRUITING · sponsor: **Vielight Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Bipolar
- Bipolar Disorder (BD)
- Bipolar Disorder Depression

## Interventions

- **DEVICE:** Vielight Neuro Rx Gamma
- **DEVICE:** Sham Device

## Key facts

- **NCT ID:** NCT07510646
- **Lead sponsor:** Vielight Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07510646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07510646, "Transcranial Photobiomodulation for Bipolar Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07510646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*